Last $12.32 USD
Change Today +0.25 / 2.07%
Volume 1.8M
As of 8:10 PM 12/17/14 All times are local (Market data is delayed by at least 15 minutes).

allscripts healthcare soluti (MDRX) Key Developments

Allscripts and Express Scripts Collaborate to Deploy Allscripts eAuth Electronic Prior Authorization Solution

Allscripts and Express Scripts have announced the deployment of Allscripts eAuth, a new electronic prior authorization (ePA) solution that transacts an electronic prior authorization for Express Scripts patients, replacing the costly, time-consuming and labor-intensive process of manual prior authorization. Allscripts eAuth is integrated within the physician electronic prescription workflow. While writing a prescription, users will be prompted to conduct prior authorization electronically with Express Scripts, saving time and leading to faster prior authorization decisions. The new feature will allow real-time provider-based prior authorization for prescriptions when required. This digital approach can decrease the need for follow-up phone calls, faxes and other manual processes related to retrospective pre-authorization which occurs after the prescription is written and which can take as long as days or weeks. Allscripts eAuth will be integrated into all Allscripts EHR platforms in the coming months.

MaineGeneral Health Selects Allscripts's FollowMyHealth as its Patient Engagement Platform

MaineGeneral Health has selected Allscripts' FollowMyHealth as its patient engagement platform to support population health management, improve patient communications and deliver positive care outcomes. MaineGeneral has agreed to continue to leverage Allscripts Sunrise and Allscripts TouchWorks electronic health records (EHR) through 2022. Allscripts FollowMyHealth provides patients with convenient online access to health information, allowing users to access needed forms, results, prescriptions and other critical information. Likewise, it streamlines communications between the patient and the care team to improve care management and outcomes. In choosing Allscripts FollowMyHealth, MaineGeneral cited the solution's features and functionality, ease of use, interoperability with existing Allscripts solutions, and superior Allscripts client support.

Catholic Health Initiatives Chooses Allscripts Remote Hosting Solution

Allscripts has announced that Catholic Health Initiatives (CHI) has selected Allscripts Hosting Solution to provide enterprise-wide information technology (IT) through 2020. CHI intends to migrate its Allscripts mission-critical clinical and financial applications, including Allscripts TouchWorks EHR, to an Allscripts remote hosting center in Kansas City, Mo. By utilizing Allscripts Hosting Solution, CHI should see improved system availability as well as enhanced end user performance and will benefit from proactive monitoring and disaster recovery services, all for a predictable monthly service fee. Using Allscripts hosting services is also expected to help reduce CHI's IT infrastructure expenditures and allow CHI to reclaim valuable data center space at its corporate headquarters.

Allscripts Healthcare Solutions, Inc. Presents at Credit Suisse Annual Healthcare Conference, Nov-12-2014 01:00 PM

Allscripts Healthcare Solutions, Inc. Presents at Credit Suisse Annual Healthcare Conference, Nov-12-2014 01:00 PM. Venue: The Biltmore, 2400 E Missouri Ave, Phoenix, AZ 85016, United States. Speakers: Richard J. Poulton, Chief Financial Officer, Principal Accounting Officer and Senior Vice President.

Allscripts Healthcare Solutions, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Records Asset Impairment Charges for the Third Quarter of 2014

Allscripts Healthcare Solutions, Inc. announced unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported total revenues of $345.4 million compared with $330.2 million for the same period a year ago. Loss from operations was $18.8 million compared with $43.5 million for the same period a year ago. Loss before income taxes was $26.2 million compared with $51.2 million for the same period a year ago. Net loss was $25.8 million or $0.15 per basic and diluted share compared with $48.9 million or $0.27 per basic and diluted share for the same period a year ago. Net cash provided by operating activities was $13.7 million compared with $12.5 million for the same period a year ago. Capital expenditures was $3.4 million compared with $11.3 million for the same period a year ago. Capitalized software was $10.3 million compared with $11.0 million for the same period a year ago. Total non-GAAP revenue was $347.7 million compared with $334.2 million for the same period a year ago. Total non-GAAP operating income was $22.7 million compared with $15.7 million for the same period a year ago. Non-GAAP net income was $11.5 million or $0.06 per basic and diluted share compared with $9.1 million or $0.05 per basic and diluted share for the same period a year ago. Adjusted EBITDA was $45.8 million compared with $39.5 million for the same period a year ago. For the nine months, the company reported total revenues of $1,037.0 million compared with $1,022.1 million for the same period a year ago. Loss from operations was $39.8 million compared with $100.1 million for the same period a year ago. Loss before income taxes was $61.5 million compared with $113.6 million for the same period a year ago. Net loss was $64.3 million or $0.36 per basic and diluted share compared with $83.4 million or $0.47 per basic and diluted share for the same period a year ago. Net cash provided by operating activities was $52.0 million compared with $63.3 million for the same period a year ago. Capital expenditures was $20.7 million compared with $57.0 million for the same period a year ago. Capitalized software was $28.3 million compared with $30.5 million for the same period a year ago. Total non-GAAP revenue was $1,046.3 million compared with $1,029.3 million for the same period a year ago. Total non-GAAP operating income was $74.9 million compared with $52.0 million for the same period a year ago. Non-GAAP net income was $39.5 million or $0.22 per basic and diluted share compared with $34.3 million or $0.19 per basic and diluted share for the same period a year ago. Adjusted EBITDA was $146.6 million compared with $131.4 million for the same period a year ago. For the quarter, the company recorded an asset impairment charge of $0.2 million compared with $7.4 for the same period a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDRX:US $12.32 USD +0.25

MDRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Accretive Health Inc $8.75 USD -0.05
Huron Consulting Group Inc $67.38 USD +1.73
MedAssets Inc $18.86 USD +0.60
Advisory Board Co/The $51.34 USD +3.06
WebMD Health Corp $38.07 USD +0.83
View Industry Companies
 

Industry Analysis

MDRX

Industry Average

Valuation MDRX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.5x
Price/Book 1.6x
Price/Cash Flow 71.5x
TEV/Sales 1.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALLSCRIPTS HEALTHCARE SOLUTI, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.